Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open, Uncontrolled Phase 3 Study to Investigate the Efficacy and Safety of a 4-phasic Oral Contraceptive SH T00658ID Containing Estradiol Valerate and Dienogest in a 28-day Regimen for 13 Cycles in Healthy Female Subjects

NCT01638910 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01638910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01638910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open, Uncontrolled Phase 3 Study to Investigate the Efficacy and Safety of a 4-phasic Oral Contraceptive SH T00658ID Containing Estradiol Valerate and Dienogest in a 28-day Regimen for 13 Cycles in Healthy Female Subjects
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2012
Completion date
November 30, 2014
Enrollment
955 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

contraception